Premorbid effects of APOE on synaptic proteins in human temporal neocortex

被引:83
作者
Love, Seth [1 ]
Siew, L. Khai
Dawbarn, David
Wilcock, Gordon K.
Ben-Shlomo, Yoav
Allen, Shelley J.
机构
[1] Univ Bristol, Dept Neuropathol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1LE, Avon, England
[2] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England
[3] Univ Bristol, Dept Care & Elderly, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1LE, Avon, England
[4] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
基金
英国医学研究理事会;
关键词
Alzheimer's disease; apolipoprotein E; normal brain; postsynaptic density-95; synapse; synaptophysin; syntaxin; 1;
D O I
10.1016/j.neurobiolaging.2005.04.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
APOE affects the risk of Alzheimer's disease (AD) and course of several other neurologic diseases. Experimental studies suggest that APOE influences synaptogenesis. We measured the concentration of two presynaptic proteins, synaptophysin and syntaxin 1, and also postsynaptic density-95 (PSD95), in superior temporal cortex from 42 AD and 160 normal brains, and determined the APOE genotypes. The concentration of both presynaptic proteins was approximately two-thirds lower in AD than normal brains and that of PSD95 one-third lower. No effect of APOE on synaptic proteins was found in advanced AD. However, in normal brain, epsilon 4 was associated with lower concentrations of all three synaptic proteins and epsilon 2 with significantly elevated PSD95 (p = 0.03). A combined measure of synaptic proteins showed a significant linear decrease from epsilon 2 through epsilon 3 to epsilon 4 (p = 0.01). APOE influences the concentration of synaptic proteins in normal superior temporal cortex and may thereby affect the response to injury, and the risk and outcome of a range of neurologic diseases. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:797 / 803
页数:7
相关论文
共 63 条
[1]   The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy [J].
Ahles, TA ;
Saykin, AJ ;
Noll, WW ;
Furstenberg, CT ;
Guerin, S ;
Cole, B ;
Mott, LA .
PSYCHO-ONCOLOGY, 2003, 12 (06) :612-619
[2]   Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype [J].
Allen, SJ ;
MacGowan, SH ;
Tyler, S ;
Wilcock, GK ;
Robertson, AGS ;
Holden, PH ;
Smith, SKF ;
Dawbarn, D .
NEUROSCIENCE LETTERS, 1997, 239 (01) :33-36
[3]   A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives [J].
Ben-Shlomo, Y ;
Kuh, D .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) :285-293
[4]  
Bickeboller H, 1997, AM J HUM GENET, V60, P439
[5]   A study of French centenarians:: are ACE and APOE associated with longevity? [J].
Blanché, H ;
Cabanne, L ;
Sahbatou, M ;
Thomas, G .
COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 2001, 324 (02) :129-135
[6]   Apolipoprotein E ε4 is associated with hippocampal volume reduction in females with alcoholism [J].
Bleich, S ;
Wilhelm, J ;
Graesel, E ;
Degner, D ;
Sperling, W ;
Rössner, V ;
Javaheripour, K ;
Kornhuber, J .
JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (04) :401-411
[7]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[8]   NEURONS BEARING NEUROFIBRILLARY TANGLES ARE RESPONSIBLE FOR SELECTED SYNAPTIC DEFICITS IN ALZHEIMERS-DISEASE [J].
CALLAHAN, LM ;
COLEMAN, PD .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :311-314
[9]   Progressive reduction of synaptophysin message in single neurons in Alzheimer disease [J].
Callahan, LM ;
Vaules, WA ;
Coleman, PD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05) :384-395
[10]   APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein [J].
Chalmers, K ;
Wilcock, GK ;
Love, S .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (03) :231-238